Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease

Author： Loschmann P.-A.   Eblen F.   Wullner U.   Wachtel H.   Klockgether T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.284, Iss.1, 1995-09, pp. : 129-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamotrigine has antidepressant activity in older epileptics

By  

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs

By Vautier Sarah   Fernandez Christine  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 11, 2009-11 ,pp. : 1349-1358

Informa Healthcare

Access to resources Recommend Favorite

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 1, 2008-01 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite

Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 6, 2012-09 ,pp. : 768-773

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models for Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1580-1594

Bentham Science Publishers

Access to resources Recommend Favorite